Dark

GILD20250425P140
GILD Apr 25 2025 140.00 Put (GILD250425P00140000)
option OPRA

Expired

Apr 21, 2025

36.750.000%(0.00)1

Overview Historical

open chart

1 day

Skyline

O36.75 H36.75 L36.75 C36.75 V1 OI1

MA 50 close 0.00

MA 200 close 0.00

Headquarters

Foster City, California, USA

Industry

Drug Manufacturers-General

Sector

Healthcare

Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.